BeStock  
Stocks › Biotechnology › MNPR

Monopar Therapeutics MNPR

US equityMarket cap rank #3666Biotechnology
$83.78 +$4.21 (+5.29%)
Pre-market · Oct 8, 9:10 am ET · After hours $83.80 +0.02%
Open$78.28
Prev close$79.57
Day range$77.98 – $85.03
Volume107.1K
Market cap$562.35M
P/E (TTM)–
Dividend yield–

MNPR Stock News

Headlines matching Monopar Therapeutics or the MNPR ticker, most recent first.

  • Piper Sandler Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $123 PositiveMarket news · 28 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $125Market news · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Reaffirms Their Buy Rating on Monopar Therapeutics Inc (MNPR)TipRanks · 22 Sep 2026 · Direct mention
  • Barclays Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $145 PositiveMarket news · 11 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $130 PositiveMarket news · 17 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Monopar Therapeutics(MNPR.US), With a Forecast Between $125 to $133Market news · 13 Aug 2026 · Direct mention
  • Barclays Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $125Market news · 23 Jul 2026 · Direct mention
  • Morgan Stanley Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $115Market news · 23 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $125 PositiveMarket news · 22 Jul 2026 · Direct mention
  • BTIG Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $117Market news · 1 Jul 2026 · Direct mention
  • Lake Street Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $103Market news · 30 Jun 2026 · Direct mention
  • A Quick Look at Today's Ratings for Monopar Therapeutics(MNPR.US), With a Forecast Between $101 to $130Market news · 30 Jun 2026 · Direct mention
  • BTIG Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $117 PositiveMarket news · 30 Jun 2026 · Direct mention
  • H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $105Market news · 3 Jun 2026 · Direct mention
  • Piper Sandler Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $101Market news · 3 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on MNPR.

Leave a comment

Scroll to Top